Anaplastic large cell lymphoma in human immunodeficiency virus‐infected people and solid organ transplant recipients. (8th June 2020)

• Record Type: Journal Article
• Authors: Mahale, Parag; Weisenburger, Dennis D.; Kahn, Amy R.; Gonsalves, Lou; Pawlish, Karen; Koch, Lori; Tirado‐Gomez, Maribel; Clarke, Christina A.; Alverson, Georgetta; Shiels, Meredith S.; Engels, Eric A.
• Is Part Of: British journal of haematology. Volume 192:Number 3(2021)
• Page Start: 514
• Page End: 521
• Publication Date: 2020-06-08
• Subjects: anaplastic large cell lymphoma -- HIV infection -- solid organ transplant -- epidemiology -- immunosuppression; Hematology -- Periodicals; Blood -- Diseases -- Periodicals; 616.15
• DOI: 10.1111/bjh.16778
• Languages: English
• ISSNs: 0007-1048

Abstract

Summary: Human immunodeficiency virus (HIV)‐infected people and solid organ transplant recipients have elevated risk of anaplastic large cell lymphoma (ALCL). Little is known regarding ALCL risk factors in immunosuppressed populations. We used data from US cancer registries linked to HIV registries (1996–2016) and to the national transplant registry (1992–2017). ALCL risk in HIV‐infected people and transplant recipients relative to the general population was calculated as a standardized incidence ratio (SIR). ALCL risk factors were evaluated using Poisson regression. We identified 121 incident ALCL cases in the HIV ( n = 86) and transplant ( n = 35) populations. We reviewed pathology reports for 45 cases and most (86·7%) were confirmed as ALCL. Epstein–Barr virus tested positive in 1/8 (12·5%) cases. Compared to the general population, ALCL risk was strongly elevated among HIV‐infected people [SIR 5·43; 95% confidence interval (CI) 4·27–6·81] and transplant recipients (5·96; 4·03–8·49). Among HIV‐infected people, ALCL incidence was strongly related to CD4 count [adjusted incidence rate ratio (aIRR) 0·15 for ≥500 vs. <200 cells/μl; P trend < 0·001]. Among transplant recipients, risk was highest within the first year (aIRR 6·82) and 10+ years post‐transplant (5·99). In conclusion, ALCL risk is strongly increased in these immunosuppressed populations but may be unrelated to EBV infection based on limited reports.